Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-046022
Filing Date
2021-07-08
Accepted
2021-07-08 17:59:18
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 3421
  Complete submission text file 0001209191-21-046022.txt   4896
Mailing Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551
Business Address 4435 NORTH FIRST STREET, SUITE 360 LIVERMORE CA 94551 925-368-8508
Acumen Pharmaceuticals, Inc. (Issuer) CIK: 0001576885 (see all company filings)

EIN.: 364108129 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACUMEN PHARMACEUTICALS, INC. 427 PARK STREET CHARLOTTESVILLE VA 22902
Business Address
Stalfort John A III (Reporting) CIK: 0001709418 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-40551 | Film No.: 211081159